These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 24967370)
1. Computational design of apolipoprotein E4 inhibitors for Alzheimer's disease therapy from traditional Chinese medicine. Huang HJ; Chen HY; Lee CC; Chen CY Biomed Res Int; 2014; 2014():452625. PubMed ID: 24967370 [TBL] [Abstract][Full Text] [Related]
2. In silico investigation of traditional Chinese medicine compounds to inhibit human histone deacetylase 2 for patients with Alzheimer's disease. Hung TC; Lee WY; Chen KB; Chan YC; Lee CC; Chen CY Biomed Res Int; 2014; 2014():769867. PubMed ID: 25045700 [TBL] [Abstract][Full Text] [Related]
3. Lead discovery for Alzheimer's disease related target protein RbAp48 from traditional Chinese medicine. Huang HJ; Lee CC; Chen CY Biomed Res Int; 2014; 2014():764946. PubMed ID: 25165715 [TBL] [Abstract][Full Text] [Related]
4. In Silico Identification of Novel Apolipoprotein E4 Inhibitor for Alzheimer's Disease Therapy. Bano S; Rasheed MA; Jamil F; Ibrahim M; Kanwal S Curr Comput Aided Drug Des; 2019; 15(1):97-103. PubMed ID: 30306878 [TBL] [Abstract][Full Text] [Related]
5. Repurposing of phyto-ligand molecules from the honey bee products for Alzheimer's disease as novel inhibitors of BACE-1: small molecule bioinformatics strategies as amyloid-based therapy. Nisa N; Rasmita B; Arati C; Uditraj C; Siddhartha R; Dinata R; Bhanushree B; Bidanchi RM; Manikandan B; Laskar SA; Abinash G; Pori B; Roy VK; Gurusubramanian G Environ Sci Pollut Res Int; 2023 Apr; 30(17):51143-51169. PubMed ID: 36808033 [TBL] [Abstract][Full Text] [Related]
6. Novel natural structure corrector of ApoE4 for checking Alzheimer's disease: benefits from high throughput screening and molecular dynamics simulations. Goyal M; Grover S; Dhanjal JK; Goyal S; Tyagi C; Chacko S; Grover A Biomed Res Int; 2013; 2013():620793. PubMed ID: 24324968 [TBL] [Abstract][Full Text] [Related]
7. In silico investigation of potential mTOR inhibitors from traditional Chinese medicine for treatment of Leigh syndrome. Chen KC; Lee WY; Chen HY; Chen CY Biomed Res Int; 2014; 2014():139492. PubMed ID: 25045657 [TBL] [Abstract][Full Text] [Related]
8. Deep Learning and Random Forest Approach for Finding the Optimal Traditional Chinese Medicine Formula for Treatment of Alzheimer's Disease. Chen HY; Chen JQ; Li JY; Huang HJ; Chen X; Zhang HY; Chen CY J Chem Inf Model; 2019 Apr; 59(4):1605-1623. PubMed ID: 30888812 [TBL] [Abstract][Full Text] [Related]
9. Identification of potential PKC inhibitors through pharmacophore designing, 3D-QSAR and molecular dynamics simulations targeting Alzheimer's disease. Iqbal S; Anantha Krishnan D; Gunasekaran K J Biomol Struct Dyn; 2018 Nov; 36(15):4029-4044. PubMed ID: 29182053 [TBL] [Abstract][Full Text] [Related]
10. Uroporphyrinogen decarboxylase as a potential target for specific components of traditional Chinese medicine: a virtual screening and molecular dynamics study. Tsou YA; Chen KC; Lin HC; Chang SS; Chen CY PLoS One; 2012; 7(11):e50087. PubMed ID: 23209648 [TBL] [Abstract][Full Text] [Related]
11. Elucidating the Aβ42 Anti-Aggregation Mechanism of Action of Tramiprosate in Alzheimer's Disease: Integrating Molecular Analytical Methods, Pharmacokinetic and Clinical Data. Kocis P; Tolar M; Yu J; Sinko W; Ray S; Blennow K; Fillit H; Hey JA CNS Drugs; 2017 Jun; 31(6):495-509. PubMed ID: 28435985 [TBL] [Abstract][Full Text] [Related]
13. Proposal of novel ApoE4 inhibitors from the natural spice Cinnamon for the treatment of Alzheimer's disease: Ab initio molecular simulations. Shaji D; Das A; Suzuki R; Nagura Y; Sabishiro H; Kurita N Biophys Chem; 2023 May; 296():106990. PubMed ID: 36898350 [TBL] [Abstract][Full Text] [Related]
14. Virtual screening, pharmacokinetics, molecular dynamics and binding free energy analysis for small natural molecules against cyclin-dependent kinase 5 for Alzheimer's disease. Shukla R; Singh TR J Biomol Struct Dyn; 2020 Jan; 38(1):248-262. PubMed ID: 30688165 [TBL] [Abstract][Full Text] [Related]
15. In Silico Design of Natural Inhibitors of ApoE4 from the Plant Shaji D; Nagura Y; Sabishiro H; Suzuki R; Kurita N Molecules; 2023 Dec; 28(24):. PubMed ID: 38138525 [TBL] [Abstract][Full Text] [Related]
16. High performance screening, structural and molecular dynamics analysis to identify H1 inhibitors from TCM Database@Taiwan. Chang SS; Huang HJ; Chen CY Mol Biosyst; 2011 Dec; 7(12):3366-74. PubMed ID: 22012120 [TBL] [Abstract][Full Text] [Related]
17. Investigation of the inhibitors of histone-lysine N-methyltransferase SETD2 for acute lymphoblastic leukaemia from traditional Chinese medicine. Chang YL; Chen HY; Chen KB; Chen KC; Chang KL; Chang PC; Chang TT; Chen YC SAR QSAR Environ Res; 2016 Jul; 27(7):589-608. PubMed ID: 27218135 [TBL] [Abstract][Full Text] [Related]
18. Computer especially AI-assisted drug virtual screening and design in traditional Chinese medicine. Lin Y; Zhang Y; Wang D; Yang B; Shen YQ Phytomedicine; 2022 Dec; 107():154481. PubMed ID: 36215788 [TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein E4 serum concentration for increased sensitivity and specificity of diagnosis of drug treated Alzheimer's disease patients vs. drug treated parkinson's disease patients vs. age-matched normal controls. Goldknopf IL; Park HR; Sabbagh M Curr Alzheimer Res; 2012 Dec; 9(10):1149-67. PubMed ID: 22950864 [TBL] [Abstract][Full Text] [Related]
20. Screening of potential drug for Alzheimer's disease: a computational study with GSK-3 β inhibition through virtual screening, docking, and molecular dynamics simulation. Elangovan ND; Dhanabalan AK; Gunasekaran K; Kandimalla R; Sankarganesh D J Biomol Struct Dyn; 2021 Nov; 39(18):7065-7079. PubMed ID: 32779973 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]